BioConsortia, Inc.

- 05/08/2025
- Unknown
- $15,000,000
BioConsortia, Inc. is revolutionizing agriculture with cutting-edge microbial solutions that boost plant health, increase yields, and promote sustainability. As leaders in gene editing and directed selection of microbes, BioConsortia harnesses the power of robust, spore-forming bacteria to develop innovative seed treatments and foliar products. The company’s proprietary Advanced Microbial Selection (AMS) process and GenePro genomics platform enable BioConsortia scientists to identify, design, and enhance microbes that help unlock the full potential of crop plants.
From nitrogen-fixing microbes that reduce reliance on synthetic fertilizers to biopesticides and biostimulants that protect crops and improve resilience, BioConsortia delivers consistent, effective products that benefit growers and the environment.
- Industry Biotechnology Research
- Website https://bioconsortia.com/
- LinkedIn https://www.linkedin.com/company/bioconsortia-inc-/
Related People
Marcus Meadows-SmithFounder

Results-oriented CEO with an impressive track record of, and passion for success. Both a strategic thinker and a rigorous executor. Proven ability to transform business performance. Strong focus on strategy, alignment and execution for true value creation. Led a portfolio of divisions with combined revenues of $1.9billion within a multinational company. Led a start-up company to successful exit. Recognized as a highly effective leader; able to inspire, coach and motivate teams to higher performance.
https://www.instagram.com/marcus.meadowssmith/
BIOCONSORTIA
• Leading the development and commercialization phase of grounding-breaking microbial start-up
BAYER CROPSCIENCE
• Integrating AgraQuest & establishing Biologics as a third strategic pillar alongside Seeds/Traits & Crop Protection products
AGRAQUEST
• Transformed PE-owned Biotechnology company from start-up to recognized market leader
• Grew at 30% CAAG; enhanced R&D pipeline; signed partnerships with BASF, Bayer, DuPont, Monsanto & Pfizer
• Sold AgraQuest to Bayer CropScience for $425 Million, ~$500 Million with milestones
CHEMTURA
• Turned around $1 Billion Plastics Additives Division. Forecasted Op Income improvement $50 Million
• Turned around $500Mil Consumer Division. Improved Op Income by 60% from $49 to $79Mil
• Led continued high performance of Crop Division. Growing sales from $320 to $400Mil
• Spearheaded recovery of Supply Chain Function. Error-free delivery metrics improved from 45% to 98%
• Drove down R&D cost by $20Mil (20%) while accelerating new product launches
• Grew Crop Protection business in Europe, ME & Africa from $87 to $120Mil in declining market
• Pioneered distribution & growth in newly created countries of Former-USSR. Grew sales from $2 to $15Mil
• Four successful M&A transactions in last 3 years